Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-24 @ 7:12 PM
NCT ID:
NCT01088503
Eligibility Criteria:
Inclusion Criteria:
* greater than or equal to 18 years of age
* diagnosed with NSTEMI or STEMI treated with a PCI during the index hospitalization
* initiated (or continued) on ADP receptor inhibitor therapy before discharge
* fully informed and are able to provide written consent for longitudinal follow-up and data collection
Exclusion Criteria:
* simultaneously participating in a research study that directs choice of either an investigational or approved ADP receptor inhibitor within the first 12 months after MI
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01088503
Study Brief:
Protocol Section:
NCT01088503